Titlebook: Antiarrhythmic Drugs; Antoni Martínez-Rubio,Juan Tamargo,Gheorghe- Andre Book 20201st edition Springer Nature Switzerland AG 2020 Antiarrh

撕成碎片

書目名稱Antiarrhythmic Drugs影響因子(影響力)




書目名稱Antiarrhythmic Drugs影響因子(影響力)學(xué)科排名




書目名稱Antiarrhythmic Drugs網(wǎng)絡(luò)公開度




書目名稱Antiarrhythmic Drugs網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Antiarrhythmic Drugs被引頻次




書目名稱Antiarrhythmic Drugs被引頻次學(xué)科排名




書目名稱Antiarrhythmic Drugs年度引用




書目名稱Antiarrhythmic Drugs年度引用學(xué)科排名




書目名稱Antiarrhythmic Drugs讀者反饋




書目名稱Antiarrhythmic Drugs讀者反饋學(xué)科排名

maintenance

Class I Antiarrhythmic Drugs: Na+ Channel Blockers, Brugada syndrome, LQT3 syndrome, familial AF, and many others. The novel indications of I. blockers such as low dose quinidine in Brugada syndrome, and Mexiletine in LQT3 syndrome, provide new therapeutic options in patients with sodium channelopathies..Discoveries of ion channels and their respect

預(yù)定

混沌

Class I Antiarrhythmic Drugs: Na+ Channel Blockers,oups, according to their cellular electrophysiologic effects. The sodium ion currents or I. enter the cell very fast during phase-0 of action potential and is responsible for depolarization..Sodium channel blockers, therefore prolong conduction time, and refractoriness of the atria, ventricle, and t

Antagonist

Fabric

FID

征兵

978-3-030-34891-5Springer Nature Switzerland AG 2020

membrane

Antoni Martínez-Rubio,Juan Tamargo,Gheorghe- AndrePresents highly practical information, written in a quick-access, no-nonsense format.Emphasis is on a just-the-facts clinical approach, heavy on tabular material, light on dense prose.Involvement of t

極小